These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1991691)

  • 1. Keynote address: integration of cytostatic agents and radiation therapy: a different approach to "proliferating" human tumors.
    Kinsella TJ; Gould MN; Mulcahy RT; Ritter MA; Fowler JF
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):295-302. PubMed ID: 1991691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors: strategies for improved locoregional control.
    Petereit DG; Harari PM; Contreras L; Pickart MA; Verma AK; Gerner EW; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):891-8. PubMed ID: 8138442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot).
    Sarkaria JN; Fowler JF; Lindstrom MJ; Jordan VC; Mulcahy RT
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):833-40. PubMed ID: 7860396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.
    McGinn CJ; Kinsella TJ
    Semin Oncol; 1992 Aug; 19(4 Suppl 11):21-8. PubMed ID: 1509278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy using cytotoxic agents and radiation therapy.
    Howes AE; Coleman CN; Phillips TL; Sutherland R
    Am J Clin Oncol; 1988 Jun; 11(3):304-12. PubMed ID: 3289363
    [No Abstract]   [Full Text] [Related]  

  • 6. Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1025-34. PubMed ID: 10571212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated repopulation: friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy.
    Marks LB; Dewhirst M
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1377-83. PubMed ID: 1938539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keynote address: hypoxic cell radiosensitizers: where next?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):987-93. PubMed ID: 2649468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
    Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of tumor curability in terms of cellular radiosensitivity and its application to physico-chemical therapy modes].
    Okada S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1432-7. PubMed ID: 2730048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects of research in radiobiology. Past and future directions].
    Hennequin C; Favaudon V
    Cancer Radiother; 2000; 4(5):385-91. PubMed ID: 11098225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor.
    Kavanagh BD; Lin PS; Chen P; Schmidt-Ullrich RK
    Clin Cancer Res; 1995 Dec; 1(12):1557-62. PubMed ID: 9815956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer.
    Shintani S; Li C; Mihara M; Terakado N; Yano J; Nakashiro K; Hamakawa H
    Int J Cancer; 2003 Dec; 107(6):1030-7. PubMed ID: 14601066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.
    Harari PM; Huang SM
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):427-33. PubMed ID: 11173137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concomitant chemo-radiation treatment of malignant tumors: biological bases].
    Inciūra A; Juozaityte E
    Medicina (Kaunas); 2002; 38(10):1042-9; quiz 1051. PubMed ID: 12532716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS; Teicher BA; Coleman CN
    Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant glioma sensitivity to radiotherapy, high-dose tamoxifen, and hypericin: corroborating clinical response in vitro: case report.
    Zhang W; Hinton DR; Surnock AA; Couldwell WT
    Neurosurgery; 1996 Mar; 38(3):587-90; discussion 590-1. PubMed ID: 8837815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale of combining radiation and interferon for the treatment of cervical cancer.
    Angioli R; Sevin BU; Perras JP; Untch M; Hightower RD; Nguyen HN; Steren A; Villani C; Averette HE
    Oncology; 1992; 49(6):445-9. PubMed ID: 1281535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.